LIVINGSTONE HEALTH HOLDINGS LIMITED

(Formerly known as Citicode Ltd.)

(Incorporated in the Republic of Singapore) (Company Registration Number 200404283C)

COMPLETION OF THE PROPOSED CAPITAL REDUCTION

1. Introduction

  1. The Board of Directors ("Board") of Livingstone Health Holdings Limited (formerly known as Citicode Ltd.) (the "Company" and together with its subsidiaries, the "Group") refers to the announcements made by the Company dated 4 June 2021, 8 July 2021, 30 July 2021 and 27 August 2021 (the "Previous Announcements"), and the circular to Shareholders dated 8 July 2021 (the "Circular") in relation to the Proposed Capital Reduction. Unless otherwise defined, capitalised terms herein shall have the same meaning as ascribed to them in the Circular.
  2. As announced in the Previous Announcement dated 30 July 2021, the Special Resolution for the Proposed Capital Reduction was duly passed by Shareholders at the EGM held on 30 July 2021.

2. Completion of Proposed Capital Reduction

  1. Further to the Previous Announcements and the Circular, the Board is pleased to announce that the Company has complied with the requirements under Section 78C(1)(c) of the Companies Act, and that no application for the cancellation of the Special Resolution for the Proposed Capital Reduction has been made by any creditor of the Company within the timeframe prescribed by the Companies Act.
  2. The Company has accordingly lodged the relevant documents required under Sections 78E(2)(i) and (ii) of the Companies Act with ACRA on 15 September 2021.
  3. The Proposed Capital Reduction is therefore effective as of 15 September 2021. Accordingly, the issued and fully paid-up share capital of the Company with effect therefrom is S$45,131,983 comprising 315,947,748 ordinary shares.

BY ORDER OF THE BOARD

Tay Ching Yit, Wilson

Executive Director and Chief Executive Officer

15 September 2021

This announcement has been reviewed by the Company's sponsor, SAC Capital Private Limited ("Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms. Tay Sim Yee at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542, Telephone (65) 6232 3210.

Attachments

  • Original document
  • Permalink

Disclaimer

Livingstone Health Holdings Ltd. published this content on 15 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 September 2021 09:51:06 UTC.